Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial [Hematologic Malignancy]
Conclusion
For recipients of alloHSCT, compared with G-CSF, prophylactic GM-CSF was associated with lower 100-day transplantation-related mortality, lower 100-day cumulative mortality, and lower 600-day IFD-related mortality.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Wan, Zhang, Lai, Jiang, Song, Zhou, Zhang, Duan, Fu, Liao, Wang Tags: Leukemia, Lymphoma Hematologic Malignancy Source Type: research
More News: Cancer & Oncology | Hematology | Leukemia | Lymphoma | Stem Cell Therapy | Stem Cells | Transplants